Prognostic significance of extent of disease in bone in patients with androgen-independent prostate cancer Academic Article uri icon

Overview

MeSH Major

  • Bone Neoplasms
  • Prostatic Neoplasms

abstract

  • The BSI quantifies the extent of skeletal involvement by tumor. It allows the identification of patients with distinct prognoses for stratification in clinical trials. Further study is needed to assess the utility of serial BSI determinations in monitoring treatment effects. The BSI may be particularly useful in the evaluation of agents for which prostate-specific antigen changes do not reflect clinical outcomes accurately.

publication date

  • March 1999

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 10071289

Additional Document Info

start page

  • 948

end page

  • 57

volume

  • 17

number

  • 3